GV Research Platform - About the company
GV Research Platform is a seed company based in Hyderabad (India), founded in 2020 by Vishal Goel, Jasmeet Singh Chhabra and Kalyan Korisapati. It operates as a Provides platform for conducting research and drug development services. GV Research Platform has raised $396K in funding, with a current valuation of ₹*****. The company has 241 active competitors, including 14 funded and 42 that have exited. Its top competitors include companies like Tigermed, Yashraj Biotechnology and Gubra.
Company Details
- Website
- gvrp.in
- Social
- Registered Address
- Sy.No.403/1(Old), 120(New), 4th Floor, Niharika Jubilee One, Road No.1, Jubilee, Hills, Hyderabad, Hyderabad, Telangana, India, 500033
Key Metrics
Founded Year
2020
Location
Hyderabad, India
Stage
Seed
Total Funding
$396K in 4 rounds
Latest Funding Round
Post Money Valuation
₹***** as on Mar 10, 2025
Investors
Ranked
5th among 241 active competitors
Annual Revenue
₹10 - ₹50 Cr as on Mar 31, 2025
Employee Count
8 as on Apr 30, 2025
Legal entities associated with GV Research Platform
GV Research Platform is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Gv Research Platform Private Limited CIN: U73100TG2018PTC154723 , India, Active | Mar 13, 2018 | ₹10 - ₹50 Cr (As on Mar 31, 2025) | 8 (As on Apr 30, 2025) |
Sign up to download GV Research Platform's company profile
GV Research Platform's funding and investors
GV Research Platform has raised a total funding of $396K over 4 rounds. Its first funding round was on Nov 17, 2022. GV Research Platform has 2 institutional investors.
Here is the list of recent funding rounds of GV Research Platform:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 10, 2025 | 9586114 | Seed | 3431646 | 3288259 | 3108359 | 4030678 |
May 06, 2024 | 4325426 | Seed | 4212652 | 6595009 | 8895028 | 2866143 |
Dec 08, 2023 | 8758492 | Seed | 4811985 | 4420956 | 5588391 | 6356658 |
Access funding benchmarks and valuations. Sign up today!View details of GV Research Platform's funding rounds and investors
GV Research Platform's founders and board of directors
Founder? Claim ProfileThe founders of GV Research Platform are Vishal Goel, Jasmeet Singh Chhabra and Kalyan Korisapati. Kalyan Korisapati is the CEO of GV Research Platform.
Here are the details of GV Research Platform's key team members:
- Vishal Goel: Co-Founder of GV Research Platform and founder of 2 other companies, Crimson Schools and JV Ventures. Contact Info: 2 email addresses and 1 phone number
- Jasmeet Singh Chhabra: Co-Founder of GV Research Platform and founder of 1 other company. Contact Info: 1 email address and 2 phone numbers
- Kalyan Korisapati: Co-Founder & CEO of GV Research Platform. Contact Info: 1 email address and 1 phone number
View details of GV Research Platform's Founder profiles and Board Members
GV Research Platform's employee count trend
GV Research Platform has 8 employees as of Apr 25. The total employee count is the same as what it was in Apr 24. Here is GV Research Platform's employee count trend over the years:
Uncover GV Research Platform's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
GV Research Platform's Competitors and alternates
Top competitors of GV Research Platform include Tigermed, Yashraj Biotechnology and Gubra. Here is the list of Top 10 competitors of GV Research Platform, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Provider of drug development and pre clinical services | - | 54/100 | ||
2nd | Yashraj Biotechnology 1999, Mumbai (India), Early Stage | Provider of recombinant antigens and antibodies for diagnostic and research | $492K | 52/100 | |
3rd | Preclinical CRO focussed on developing treatments for NAFLD/NASH, diabetes, and obesity | - | - | 49/100 | |
4th | BioQual 1981, Rockville (United States), Public | Integrated CRO focused on infectious diseases | - | - | 48/100 |
5th |  GV Research Platform 2020, Hyderabad (India), Seed | Provides platform for conducting research and drug development services | $396K | 47/100 | |
6th | Gentronix 1999, Alderley Edge (United Kingdom), Acquired | Providr of in-vitro and in-vivo genetic toxicology screening services | $3.84M | 47/100 | |
7th |  Shanghai Semero Biotechnology 2014, Shanghai (China), Series C | Provider of diversified preclinical services for brain-related disorders | $20.8M | 43/100 | |
8th |  Dream CIS 2000, Seoul (South Korea), Public | Provider of clinical research services | - | 42/100 | |
9th | RxCelerate 2012, Babraham (United Kingdom), Seed | Provider of pre-clinical contract research services | - | 41/100 | |
10th |  BioEmission Tech 2013, Agia Paraskevi (Greece), Seed | Provider of preclinical research services and imaging systems. It offers a complete suite of preclinical services, encompassing in vitro assays, stem cell therapy, radionuclide therapy, molecular imaging, GLP toxicology, and disease models. Additionally, it manufactures and provides novel imaging systems, along with associated software tools to support research workflows. The company supports scientists throughout the preclinical research process, aiming to accelerate the translation of promising drugs into clinical applications. Its services follow Good Laboratory Practice standards. | - | 41/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on GV Research Platform's competitors? Click here to see the top ones
GV Research Platform's Investments and acquisitions
GV Research Platform has made no investments or acquisitions yet.
Reports related to GV Research Platform
Here is the latest report on GV Research Platform's sector:
News related to GV Research Platform
Media has covered GV Research Platform for a total of 2 events in the last 1 year, 2 of them have been about partnerships.
•
GVRP and Yurogen Biosystems Partner to Enhance Biologics Drug Discovery in IndiaBusinessFortNight•Feb 20, 2026•GV Research Platform, Yurogen Biosystems
•
GVSAP and Biocytogen Expand Collaboration to Strengthen Translational Research in IndiaThe Tribune•Feb 05, 2026•GV Research Platform, Biocytogen
•
GV & BeCytes boost Indian biopharma research with better access to liver cells & samples.Business Wire India•Feb 03, 2025•GV Research Platform, BeCytes Biotechnologies
•
GV Research Platform and BeCytes partner to advance biopharma research in IndiaBioSpectrum India•Feb 03, 2025•GV Research Platform, BeCytes Biotechnologies
•
GV Safety Assessment Platform (GVSAP) and Biocytogen Forge Strategic Collaboration to Accelerate Biopharmaceutical InnovationDevdiscourse•May 17, 2024•GV Research Platform, Biocytogen
•
India's GVSAP collaborates with China-based Biocytogen to accelerate biopharma innovationBioSpectrum Asia•May 17, 2024•GV Research Platform, Biocytogen
•
GV Research Platform Transforms Safety Assessment Practices in India with SenzaGen PartnershipJul 07, 2023•Senzagen, GV Research Platform
•
GV Research Platform and Nexel Partner to Bring Cutting-Edge iPSC Technology to the Biomedical Community in IndiaBusiness Wire India•Mar 22, 2023•GV Research Platform, NEXEL, http://nexelshelving.net
•
GVRP opens flagship preclinical research facility in HyderabadBioSpectrum India•Oct 19, 2022•GV Research Platform
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about GV Research Platform
Explore our recently published companies
- BAMBUHOKI88 - Unfunded company
- Bao Tie - China based, Unfunded company
- Bapex Suite - Unfunded company
